Automated erythrocytapheresis for severe falciparum malaria

Internal Medicine Journal

Volumn 41, Issue 1 A, 2011, Pages 60-63

  Harris, P ^a   Price, S ^b   Senthuran, S ^c   Cochupanachimootil, J ^d   Norton, R ^a  

^a Pathology Queensland   (Australia)

^b Departments of Haematology and Oncology   (Australia)

^c Department of Intensive Care ^*  (Australia)

^d TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Erythrocytapheresis; Hyperparasitaemia; Plasmodium falciparum; Red cell exchange transfusion; Severe malaria

Indexed keywords

ARTESUNATE;

ADULT; ARTICLE; AUTOMATION; CASE REPORT; CYTAPHERESIS; DEVICE; DISEASE SEVERITY; ERYTHROCYTAPHERESIS; HEADACHE; HUMAN; LUNG EDEMA; MALARIA FALCIPARUM; MALE; MORBIDITY; MORTALITY; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; ANTIMALARIALS; ARTEMISININS; AUSTRALIA; AUTOMATION; BLOOD COMPONENT REMOVAL; CAMBODIA; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; PARASITEMIA; TRAVEL;

EID: 79251470133     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02362.x     Document Type: Article

References (16)

1. Charles DM, Hart J, Davis WA, Sullivan E, Dowse GK, Davis TM. Notifications of imported malaria in Western Australia, 1990-2001: incidence, associated factors and chemoprophylaxis. Med J Aust 2005; 182: 164-7.
2. Field JW. Blood examination and prognosis in acute falciparum malaria. Trans Roy Soc Trop Med Hyg 1949; 43: 33-48.
3. Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R etal. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007; 22: 106-75.
4. Wilkinson RJ, Brown JL, Pasvol G, Chiodini PL, Davidson RN. Severe falciparum malaria: predicting the effect of exchange transfusion. QJM 1994; 87: 553-7.
5. Nieuwenhuis JA, Meertens JH, Zijlstra JG, Ligtenberg JJ, Tulleken JE, van der Werf TS. Automated erythrocytapheresis in severe falciparum malaria: a critical appraisal. Acta Trop 2006; 98: 201-6.
6. Balint B, Ostojic G, Pavlovic M, Hrvacevic R, Pavlovic M, Tukic L etal. Cytapheresis in the treatment of cell-affected blood disorders and abnormalities. Transfus Apher Sci 2006; 35: 25-31.
7. Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366: 717-25.
8. White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997; 41: 1413-22.
9. Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 2002; 34: 1192-8.
10. Whitty CJ, Lalloo D, Ustianowski A. Malaria: an update on treatment of adults in non-endemic countries. BMJ 2006; 333: 241-5.
11. Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ etal. UK malaria treatment guidelines. J Infect 2007; 54: 111-21.
12. Zucker JR, Campbell CC. Malaria. Principles of prevention and treatment. Infect Dis Clin North Am 1993; 7: 547-67.
13. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA 2007; 297: 2264-77.
14. Severe Falciparum Malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg 2000; 94 (Suppl 1): S1-90.
15. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J etal. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-67.
16. Macallan DC, Pocock M, Robinson GT, Parker-Williams J, Bevan DH. Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers. Trans R Soc Trop Med Hyg 2000; 94: 353-6.